Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Osiris Therapeutics, Inc.

Osiris Therapeutics shares soared 35.31 percent on volume of nearly 1 million shares traded Wednesday to close at $9.35 a share. The company reported Biosurgery product revenues totaled $7.8 million in 2012, an increase of 520 percent when compared to a year ago. Piper Jaffray has recently upgraded Osiris Therapeutics’ rating to “overweight” from “neutral”.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on